BioNeutra Global (BGA) Financial Statements
BioNeutra Global Financial Overview
BioNeutra Global's market cap is currently $1.39M. The company's EPS TTM is ―; its P/E ratio is ―; BioNeutra Global is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 4.14M | $ 13.39M | $ 2.89M | $ 3.94M | $ 638.16K |
| Operating Income | $ -1.48M | $ 8.56M | $ -2.36M | $ -3.03M | $ -9.83M |
| EBITDA | $ -351.91K | $ 9.68M | $ -1.12M | $ -1.50M | $ -10.10M |
| Net Income | $ -2.11M | $ 8.12M | $ -2.83M | $ -3.71M | $ -12.44M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 19.06M | $ 21.10M | $ 21.08M | $ 23.68M | $ 34.02M |
| Total Debt | $ 7.64M | $ 7.01M | $ 6.89M | $ 7.07M | $ 7.58M |
| Net Debt | $ 5.75M | $ 6.28M | $ 6.05M | $ 6.14M | $ 7.06M |
| Total Liabilities | $ 21.96M | $ 23.54M | $ 22.12M | $ 22.98M | $ 29.27M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | ― | $ 641.04K | $ 271.05K | $ 1.43M | $ 707.55K |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD